Episodes

  • Podcast - Practical GP Discussions: Tirzepatide for Obesity – NHS Access Explained

    Podcast - Practical GP Discussions: Tirzepatide for Obesity – NHS Access Explained
    Feb 3 2025

    The video version of this episode can be found here:

    · https://youtu.be/3KFod0_RiAI

    This episode makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE.

    NICE stands for "National Institute for Health and Care Excellence" and is an independent organization within the UK healthcare system that produces evidence-based guidelines and recommendations to help healthcare professionals deliver the best possible care to patients, particularly within the NHS (National Health Service) by assessing new health technologies and treatments and determining their cost-effectiveness; essentially guiding best practices for patient care across the country.

    My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode, I use AI voices to discuss the NICE technology appraisal on Tirzepatide for managing overweight and obesity or TA1026, published in December 2024, focusing on what is relevant to Primary Care only. In particular, I also make reference to NHS implementation information and guidance.

    I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement.

    Disclaimer:

    The Video Content on this channel is for educational purposes and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this YouTube channel. The statements made throughout this video are not to be used or relied on to diagnose, treat, cure or prevent health conditions.

    In addition, transmission of this Content is not intended to create, and receipt by you does not constitute, a physician-patient relationship with Dr Fernando Florido, his employees, agents, independent contractors, or anyone acting on behalf of Dr Fernando Florido.

    There is a YouTube version of this and other videos that you can access here:

    • The Practical GP YouTube Channel:

    https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk


    The technology appraisal on Tirzepatide for managing overweight and obesity [TA1026] can be found here:

    · https://www.nice.org.uk/guidance/ta1026


    The section on implementation of the technology appraisal on Tirzepatide for managing overweight and obesity [TA1026] can be found here:

    · https://www.nice.org.uk/guidance/ta1026/chapter/4-Implementation

    The link to the NICE News- December 2024 discussing TA1026 can be accessed here:

    · https://youtu.be/Od1QDebGbBQ?si=EsJhm3IavpWu8ZC_
    Show more Show less
    20 mins
  • Podcast - The Kidney Chronicles: Bridging the Renal Gap with NICE - Part 2

    Podcast - The Kidney Chronicles: Bridging the Renal Gap with NICE - Part 2
    Jan 29 2025
    The video version of this podcast can be found here: · https://youtu.be/6WtRlgjCt34The previous episode on diagnosis, and classification of CKD can be found here:· https://youtu.be/iJKpE3H_LbkThis episode makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE.NICE stands for "National Institute for Health and Care Excellence" and is an independent organization within the UK healthcare system that produces evidence-based guidelines and recommendations to help healthcare professionals deliver the best possible care to patients, particularly within the NHS (National Health Service) by assessing new health technologies and treatments and determining their cost-effectiveness; essentially guiding best practices for patient care across the country.My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode I go through the guideline on CKD, NG203, by the National Institute for Health and Care Excellence (NICE), last updated in November 2021, focusing on what is relevant to Primary Care only. Given how extensive the guidance is, in this episode I will just focus on investigations, monitoring, referral recommendation and BP management in CKDI recommend checking out the previous episode on diagnosis, and classification of CKD. In the next episode, I will cover referral the rest CKD management in Primary care, including renal anaemia and mineral bone disease in CKD. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Disclaimer:The Video Content on this channel is for educational purposes and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this YouTube channel. The statements made throughout this video are not to be used or relied on to diagnose, treat, cure or prevent health conditions. In addition, transmission of this Content is not intended to create, and receipt by you does not constitute, a physician-patient relationship with Dr Fernando Florido, his employees, agents, independent contractors, or anyone acting on behalf of Dr Fernando Florido. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148 There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk The Full NICE guideline chronic kidney disease: assessment and management [NG203] can be found here:· https://www.nice.org.uk/guidance/ng203The links to other relevant guidance covered in this episode can be found here: The table showing the minimum number of monitoring checks per year is: · https://www.nice.org.uk/guidance/ng203/chapter/Recommendations#frequency-of-monitoringThe 4-variable Kidney Failure Risk Equation can be found here: · https://www.nice.org.uk/guidance/ng203/chapter/recommendations#variable-kidney-failure-risk-equation A Kidney Failure Risk Equation calculator can be found here: · https://ukidney.com/calculators/kidney-failure-risk-equation-kfre The NICE technology appraisal guidance on SGLT2 inhibitors for adults with CKD, can be found here:Empagliflozin (TA942, 2023): https://www.nice.org.uk/guidance/ta942/chapter/1-RecommendationsDapagliflozin (TA775, 2022): https://www.nice.org.uk/guidance/ta775/chapter/1-RecommendationsThe recommendations on hyperkalaemia treatment in adults with categories G3b to G5 chronic kidney disease can be found here:· Zirconium: https://www.nice.org.uk/guidance/ta599· Patiromer: https://www.nice.org.uk/guidance/ta623 The link to the hypertension video can be found here: · https://youtu.be/wjIbwy9SdAQ?si=dsPA_Wc6uvxhNANd The links to the videos on cardiovascular disease risk reduction and lipid modification can be found here: ·...
    Show more Show less
    10 mins
  • Podcast - Practical GP Discussions: Enhancing GP learning with AI

    Podcast - Practical GP Discussions: Enhancing GP learning with AI
    Jan 27 2025

    The video version of this episode can be found here:

    · https://youtu.be/qvrWEoYnznw

    My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode, I introduce a new approach to video creation using AI, focusing on what is relevant to Primary Care only.

    I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement.

    Disclaimer:

    The Video Content on this channel is for educational purposes and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this YouTube channel. The statements made throughout this video are not to be used or relied on to diagnose, treat, cure or prevent health conditions.

    In addition, transmission of this Content is not intended to create, and receipt by you does not constitute, a physician-patient relationship with Dr Fernando Florido, his employees, agents, independent contractors, or anyone acting on behalf of Dr Fernando Florido.

    Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release]

    • Music provided by Audio Library Plus
    • Watch: https://youtu.be/aBGk6aJM3IU
    • Free Download / Stream: https://alplus.io/halfway-through


    There is a YouTube version of this and other videos that you can access here:

    • The Practical GP YouTube Channel:

    https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk
    Show more Show less
    9 mins
  • Podcast - The Kidney Chronicles: Bridging the Renal Gap with NICE - Part 1

    Podcast - The Kidney Chronicles: Bridging the Renal Gap with NICE - Part 1
    Jan 22 2025
    The video version of this podcast can be found here: · https://youtu.be/iJKpE3H_LbkThis episode makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE.NICE stands for "National Institute for Health and Care Excellence" and is an independent organization within the UK healthcare system that produces evidence-based guidelines and recommendations to help healthcare professionals deliver the best possible care to patients, particularly within the NHS (National Health Service) by assessing new health technologies and treatments and determining their cost-effectiveness; essentially guiding best practices for patient care across the country.My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode I go through the guideline on CKD, NG203, by the National Institute for Health and Care Excellence (NICE), last updated in November 2021, focusing on what is relevant to Primary Care only. Given how extensive the guidance is, in this episode I will just focus on diagnosis, and classification of CKD. In the next two episodes, I will cover investigations, monitoring, referral recommendation and CKD management in Primary care. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Disclaimer:The Video Content on this channel is for educational purposes and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this YouTube channel. The statements made throughout this video are not to be used or relied on to diagnose, treat, cure or prevent health conditions. In addition, transmission of this Content is not intended to create, and receipt by you does not constitute, a physician-patient relationship with Dr Fernando Florido, his employees, agents, independent contractors, or anyone acting on behalf of Dr Fernando Florido. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148 There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk The Full NICE guideline chronic kidney disease: assessment and management [NG203] can be found here:· https://www.nice.org.uk/guidance/ng203The links to other relevant guidance covered in this episode can be found here: The link to the non-visible haematuria video is: · https://youtu.be/SaizjWg7Fng?si=McvEYQO9O3chElkj TranscriptIf you are listening to this podcast on YouTube, for a better experience, switch to the video version. The link is in the top right corner of the video and in the episode description.Hello and welcome, I am Fernando, a GP in the UK. Today, we are doing a review of the NICE guideline on CKD, or NG203, focusing what is relevant to Primary Care only. Given how extensive the guidance is, in this episode I will just focus on diagnosis, and classification of CKD. In the next two episodes, I will cover investigations, monitoring, referral recommendation and CKD management in Primary care, so stay tuned for those.Right, let’s jump into it.For this review, I have excluded recommendations related to children and young people with CKD. While their management is often similar to that of adults, most children with CKD are managed by secondary care and this is why I am focusing on adultsLet’s review the investigations recommended in CKD. CKD can be classified depending on the levels of renal function and the presence and degree of proteinuria. So, let’s have a look at renal function first.To assess kidney function, path labs should report a creatinine-based estimate of glomerular filtration rate, or eGFRcreatinine, alongside the serum creatinine result. For simplicity, from now on, I’ll refer to eGFRcreatinine simply as eGFR. Because of how eGFR is calculated, eGFR results may be less ...
    Show more Show less
    10 mins
  • Podcast - NICE News - December 2024

    Podcast - NICE News - December 2024
    Jan 15 2025
    The video version of this podcast can be found here: · https://youtu.be/Od1QDebGbBQThis episode makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE.NICE stands for "National Institute for Health and Care Excellence" and is an independent organization within the UK healthcare system that produces evidence-based guidelines and recommendations to help healthcare professionals deliver the best possible care to patients, particularly within the NHS (National Health Service) by assessing new health technologies and treatments and determining their cost-effectiveness; essentially guiding best practices for patient care across the country.My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode I go through new and updated recommendations published in December 2024 by the National Institute for Health and Care Excellence (NICE), focusing on those that are relevant to Primary Care only. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Disclaimer:The Video Content on this channel is for educational purposes and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this YouTube channel. The statements made throughout this video are not to be used or relied on to diagnose, treat, cure or prevent health conditions. In addition, transmission of this Content is not intended to create, and receipt by you does not constitute, a physician-patient relationship with Dr Fernando Florido, his employees, agents, independent contractors, or anyone acting on behalf of Dr Fernando Florido. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148 There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk The Full NICE News bulletin for December 2024 can be found here:· https://www.nice.org.uk/guidance/published?from=2024-12-01&to=2024-12-31&ndt=Guidance&ndt=Quality+standard The links to the guidance covered in this episode can be found here: Tirzepatide for managing overweight and obesity: · https://www.nice.org.uk/guidance/ta1026 Urinary tract infection (recurrent): antimicrobial prescribing: · https://www.nice.org.uk/guidance/ng112 Meningitis (bacterial) and meningococcal disease: · https://www.nice.org.uk/guidance/qs19 TranscriptIf you are listening to this podcast on YouTube, for a better experience, switch to the video version. The link is in the top right corner of the video and in the episode description.Hello and welcome, I am Fernando, a GP in the UK. Today, we are looking at the NICE updates published in December 2024, focusing on what is relevant in Primary Care only. In today’s episode, we’re covering two important clinical topics:Tirzepatide for managing overweight and obesity, andAntimicrobial prescribing for recurrent UTIs.But before we jump into the details, let’s take a moment to highlight a game-changing development: the new NICE technology appraisal on Tirzepatide.For many GPs, the surge in patient requests for Ozempic (or semaglutide) to manage obesity has been a challenging situation, especially as NICE does not recommend its use in primary care for this purpose. Could Tirzepatide mark the end of the GP Ozempic nightmare?Right, let’s find out!In the technology appraisal assessing Tirzepatide for overweight and obesity NICE has recommended it as an option for adults, alongside diet and exercise only if they have:an initial BMI of at least 35 kg/m2 reduced to 32.5 for people from Asian, Chinese, Middle Eastern, and Black African or African-Caribbean ethnic backgrounds. andat least 1 weight-related comorbidity. Examples would be, for example, hypertension, dyslipidaemia, ...
    Show more Show less
    11 mins
  • Podcast - The Asthma Revolution Part 4: New Monitoring Advice and Special Groups

    Podcast - The Asthma Revolution Part 4: New Monitoring Advice and Special Groups
    Jan 8 2025
    The video version of this podcast can be found here: · https://youtu.be/jWp08v7niLsThis channel may make reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE. My name is Fernando Florido (also known as Juan Fernando Florido Santana), a GP in the UK. In this episode, I will go through the new NICE guideline on diagnosing, monitoring, and managing chronic asthma, NG245, focusing on what is relevant in Primary Care only. Given how extensive the guidance is, in this episode I will just focus on asthma monitoring, general treatment principles, and asthma management in special groups If you haven’t already, I recommend checking out the previous three episodes on this subject covering “initial assessment and diagnosis”, “asthma treatment in patients aged 12 and over” and “asthma treatment in children aged 5 to 11, and those under 5” The new guideline is a collaborative initiative developed by NICE, the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN). It replaces previous guidance, and you’ll find a link to it in the episode description. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148 There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrk The link to the new collaborative NICE guideline on chronic asthma can be found here:· https://www.nice.org.uk/guidance/ng245The table on alternative diagnoses in wheezy children in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/bts-nice-and-sign-asthma-pathway/diagnosis/alternative-diagnoses-in-wheezy-children/The table on alternative diagnoses in adults in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/asthma-pathway-bts-nice-sign-sign-244/diagnosis/alternative-diagnoses-in-adults/The algorithm A for a summary of objective tests for diagnosing asthma in adults and young people (aged over 16 years) with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/bts-nice-and-sign-algorithm-a-summary-of-objective-tests-for-diagnosing-asthma-pdf-13556516365The algorithm B for a summary of objective tests for diagnosing asthma in children aged 5 to 16 with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-b-objective-tests-for-diagnosing-asthma-in-children-aged-5-to-16-with-a-history-pdf-13556516366The algorithm C for a summary of the pharmacological management of asthma in people aged 12 years and over can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-c-pharmacological-management-of-asthma-in-people-aged-12-years-and-over-bts-nice-pdf-13556516367The algorithm D for a summary of the pharmacological management of asthma in children aged 5 to 11 years can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-d-pharmacological-management-of-asthma-in-children-aged-5-to-11-years-bts-nice-sign-pdf-13556516368The algorithm E for a summary of the pharmacological management of asthma in children under 5 can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-e-pharmacological-management-of-asthma-in-children-under-5-bts-nice-sign-pdf-13556516369The MHRA safety advice on the risk of neuropsychiatric reactions in people taking montelukast can be found here:· https://www.gov.uk/drug-safety-update/montelukast-reminder-of-the-risk-of-neuropsychiatric-reactionsThe table of inhaled corticosteroid doses for the BTS, NICE and SIGN asthma guideline can be found here:· https://www.nice.org.uk/guidance/ng245/resources/inhaled-corticosteroid-doses-for-the-bts-nice-and-sign-asthma-guideline-pdf-...
    Show more Show less
    12 mins
  • Podcast - The Asthma Revolution Part 3: New Treatment Advice for Ages under 12

    Podcast - The Asthma Revolution Part 3: New Treatment Advice for Ages under 12
    Jan 1 2025
    The video version of this podcast can be found here:· https://youtu.be/4sbHjioaudIThis channel may make reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE. My name is Fernando Florido (also known as Juan Fernando Florido Santana), a GP in the UK. In this episode, I will go through the new NICE guideline on diagnosing, monitoring, and managing chronic asthma, NG245, focusing on what is relevant in Primary Care only. Given how extensive the guidance is, in this episode I will just focus on treating asthma in children aged 5 to 11, and those under 5 If you haven’t already, I recommend checking out the previous two episodes on this subject covering “initial assessment and diagnosis” and the “asthma treatment in patients aged 12 and over” In the next episode, we will finish the guideline by covering: And finally, Asthma monitoring, general treatment principles, and management in special groups The new guideline is a collaborative initiative developed by NICE, the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN). It replaces previous guidance, and you can find a link to it in the episode description. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrkThe link to the new collaborative NICE guideline on chronic asthma can be found here:· https://www.nice.org.uk/guidance/ng245The table on alternative diagnoses in wheezy children in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/bts-nice-and-sign-asthma-pathway/diagnosis/alternative-diagnoses-in-wheezy-children/The table on alternative diagnoses in adults in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/asthma-pathway-bts-nice-sign-sign-244/diagnosis/alternative-diagnoses-in-adults/The algorithm A for a summary of objective tests for diagnosing asthma in adults and young people (aged over 16 years) with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/bts-nice-and-sign-algorithm-a-summary-of-objective-tests-for-diagnosing-asthma-pdf-13556516365The algorithm B for a summary of objective tests for diagnosing asthma in children aged 5 to 16 with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-b-objective-tests-for-diagnosing-asthma-in-children-aged-5-to-16-with-a-history-pdf-13556516366The algorithm C for a summary of the pharmacological management of asthma in people aged 12 years and over can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-c-pharmacological-management-of-asthma-in-people-aged-12-years-and-over-bts-nice-pdf-13556516367The algorithm D for a summary of the pharmacological management of asthma in children aged 5 to 11 years can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-d-pharmacological-management-of-asthma-in-children-aged-5-to-11-years-bts-nice-sign-pdf-13556516368The algorithm E for a summary of the pharmacological management of asthma in children under 5 can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-e-pharmacological-management-of-asthma-in-children-under-5-bts-nice-sign-pdf-13556516369The MHRA safety advice on the risk of neuropsychiatric reactions in people taking montelukast can be found here:· https://www.gov.uk/drug-safety-update/montelukast-reminder-of-the-risk-of-neuropsychiatric-reactionsThe table of inhaled corticosteroid doses for the BTS, NICE and SIGN asthma guideline can be found here:· https://www.nice.org.uk/guidance/ng245/resources/...
    Show more Show less
    13 mins
  • Podcast - The Asthma Revolution Part 2: New Treatment Advice for Ages 12+

    Podcast - The Asthma Revolution Part 2: New Treatment Advice for Ages 12+
    Dec 25 2024
    The video version of this podcast can be found here:· https://youtu.be/Mef3NziRsMEThis channel may make reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". The content on this channel reflects my professional interpretation/summary of the guidance and I am in no way affiliated with, employed by or funded/sponsored by NICE. My name is Fernando Florido (also known as Juan Fernando Florido Santana), a GP in the UK. In this episode, I will go through the new NICE guideline on diagnosing, monitoring, and managing chronic asthma, NG245, focusing on what is relevant in Primary Care only. Given how extensive the guidance is, in this episode I will just focus on treating asthma in patients aged 12 and over. If you haven’t already, I recommend checking out the previous episode on initial assessment and diagnosis. In the next two episodes, I will finish the guideline by covering: · Treating asthma in children aged 5 to 11, and those under 5· Asthma monitoring, general treatment principles, and management in special groups The new guideline is a collaborative initiative developed by NICE, the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN). It replaces previous guidance, and you can find a link to it in the episode description. I am not giving medical advice; this video is intended for health care professionals, it is only my summary and my interpretation of the guidelines and you must use your clinical judgement. Intro / outro music: Track: Halfway Through — Broke In Summer [Audio Library Release] Music provided by Audio Library Plus Watch: https://youtu.be/aBGk6aJM3IU Free Download / Stream: https://alplus.io/halfway-through There is a podcast version of this and other videos that you can access here: Primary Care guidelines podcast: · Redcircle: https://redcircle.com/shows/primary-care-guidelines· Spotify: https://open.spotify.com/show/5BmqS0Ol16oQ7Kr1WYzupK· Apple podcasts: https://podcasts.apple.com/gb/podcast/primary-care-guidelines/id1608821148There is a YouTube version of this and other videos that you can access here: The Practical GP YouTube Channel: https://youtube.com/@practicalgp?si=ecJGF5QCuMLQ6hrkThe link to the new collaborative NICE guideline on chronic asthma can be found here:· https://www.nice.org.uk/guidance/ng245The table on alternative diagnoses in wheezy children in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/bts-nice-and-sign-asthma-pathway/diagnosis/alternative-diagnoses-in-wheezy-children/The table on alternative diagnoses in adults in the BTS/SIGN British guideline on the management of asthma SIGN 158 can be found here: · https://rightdecisions.scot.nhs.uk/asthma-pathway-bts-nice-sign-sign-244/diagnosis/alternative-diagnoses-in-adults/The algorithm A for a summary of objective tests for diagnosing asthma in adults and young people (aged over 16 years) with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/bts-nice-and-sign-algorithm-a-summary-of-objective-tests-for-diagnosing-asthma-pdf-13556516365The algorithm B for a summary of objective tests for diagnosing asthma in children aged 5 to 16 with a history suggesting asthma can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-b-objective-tests-for-diagnosing-asthma-in-children-aged-5-to-16-with-a-history-pdf-13556516366The algorithm C for a summary of the pharmacological management of asthma in people aged 12 years and over can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-c-pharmacological-management-of-asthma-in-people-aged-12-years-and-over-bts-nice-pdf-13556516367The algorithm D for a summary of the pharmacological management of asthma in children aged 5 to 11 years can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-d-pharmacological-management-of-asthma-in-children-aged-5-to-11-years-bts-nice-sign-pdf-13556516368The algorithm E for a summary of the pharmacological management of asthma in children under 5 can be found here:· https://www.nice.org.uk/guidance/ng245/resources/algorithm-e-pharmacological-management-of-asthma-in-children-under-5-bts-nice-sign-pdf-13556516369The MHRA safety advice on the risk of neuropsychiatric reactions in people taking montelukast can be found here:· https://www.gov.uk/drug-safety-update/montelukast-reminder-of-the-risk-of-neuropsychiatric-reactionsThe table of inhaled corticosteroid doses for the BTS, NICE and SIGN asthma guideline can be found here:· https://www.nice.org.uk/guidance/ng245/resources/...
    Show more Show less
    10 mins